nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Melphalan—peripheral nervous system neoplasm	0.289	0.556	CiPCiCtD
Carmustine—malignant glioma—peripheral nervous system neoplasm	0.25	0.666	CtDrD
Carmustine—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.231	0.444	CiPCiCtD
Carmustine—brain cancer—peripheral nervous system neoplasm	0.125	0.334	CtDrD
Carmustine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0169	0.456	CbGbCtD
Carmustine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0135	0.365	CbGbCtD
Carmustine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00661	0.179	CbGbCtD
Carmustine—GSR—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.000162	0.434	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	5.02e-05	0.134	CbGpPWpGaD
Carmustine—Dizziness—Tretinoin—peripheral nervous system neoplasm	3.4e-05	0.000495	CcSEcCtD
Carmustine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	3.4e-05	0.000495	CcSEcCtD
Carmustine—Insomnia—Vincristine—peripheral nervous system neoplasm	3.4e-05	0.000495	CcSEcCtD
Carmustine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	3.39e-05	0.000494	CcSEcCtD
Carmustine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	3.37e-05	0.000491	CcSEcCtD
Carmustine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	3.36e-05	0.00049	CcSEcCtD
Carmustine—Face oedema—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000488	CcSEcCtD
Carmustine—Leukopenia—Etoposide—peripheral nervous system neoplasm	3.34e-05	0.000486	CcSEcCtD
Carmustine—Pain—Alitretinoin—peripheral nervous system neoplasm	3.33e-05	0.000486	CcSEcCtD
Carmustine—Constipation—Alitretinoin—peripheral nervous system neoplasm	3.33e-05	0.000486	CcSEcCtD
Carmustine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	3.32e-05	0.000484	CcSEcCtD
Carmustine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	3.32e-05	0.000484	CcSEcCtD
Carmustine—Oedema—Cisplatin—peripheral nervous system neoplasm	3.32e-05	0.000484	CcSEcCtD
Carmustine—Infection—Cisplatin—peripheral nervous system neoplasm	3.3e-05	0.000481	CcSEcCtD
Carmustine—Vomiting—Topotecan—peripheral nervous system neoplasm	3.3e-05	0.00048	CcSEcCtD
Carmustine—Vomiting—Tretinoin—peripheral nervous system neoplasm	3.27e-05	0.000476	CcSEcCtD
Carmustine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	3.27e-05	0.000476	CcSEcCtD
Carmustine—Rash—Topotecan—peripheral nervous system neoplasm	3.27e-05	0.000476	CcSEcCtD
Carmustine—Dermatitis—Topotecan—peripheral nervous system neoplasm	3.26e-05	0.000476	CcSEcCtD
Carmustine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	3.26e-05	0.000476	CcSEcCtD
Carmustine—Ataxia—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000475	CcSEcCtD
Carmustine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	3.25e-05	0.000474	CcSEcCtD
Carmustine—Headache—Topotecan—peripheral nervous system neoplasm	3.25e-05	0.000473	CcSEcCtD
Carmustine—Rash—Tretinoin—peripheral nervous system neoplasm	3.24e-05	0.000472	CcSEcCtD
Carmustine—Rash—Isotretinoin—peripheral nervous system neoplasm	3.24e-05	0.000472	CcSEcCtD
Carmustine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	3.24e-05	0.000472	CcSEcCtD
Carmustine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	3.24e-05	0.000472	CcSEcCtD
Carmustine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	3.24e-05	0.000472	CcSEcCtD
Carmustine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	3.24e-05	0.000472	CcSEcCtD
Carmustine—Convulsion—Etoposide—peripheral nervous system neoplasm	3.23e-05	0.000471	CcSEcCtD
Carmustine—Vomiting—Melphalan—peripheral nervous system neoplasm	3.23e-05	0.00047	CcSEcCtD
Carmustine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.00047	CcSEcCtD
Carmustine—Headache—Isotretinoin—peripheral nervous system neoplasm	3.22e-05	0.000469	CcSEcCtD
Carmustine—Headache—Tretinoin—peripheral nervous system neoplasm	3.22e-05	0.000469	CcSEcCtD
Carmustine—Hypertension—Etoposide—peripheral nervous system neoplasm	3.22e-05	0.000469	CcSEcCtD
Carmustine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	3.21e-05	0.000468	CcSEcCtD
Carmustine—Pain—Vincristine—peripheral nervous system neoplasm	3.21e-05	0.000468	CcSEcCtD
Carmustine—Constipation—Vincristine—peripheral nervous system neoplasm	3.21e-05	0.000468	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000468	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000468	CcSEcCtD
Carmustine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000467	CcSEcCtD
Carmustine—Rash—Melphalan—peripheral nervous system neoplasm	3.2e-05	0.000466	CcSEcCtD
Carmustine—Dermatitis—Melphalan—peripheral nervous system neoplasm	3.2e-05	0.000466	CcSEcCtD
Carmustine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	3.19e-05	0.000464	CcSEcCtD
Carmustine—Chest pain—Etoposide—peripheral nervous system neoplasm	3.17e-05	0.000462	CcSEcCtD
Carmustine—Anorexia—Cisplatin—peripheral nervous system neoplasm	3.16e-05	0.000461	CcSEcCtD
Carmustine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.00046	CcSEcCtD
Carmustine—Hypotension—Cisplatin—peripheral nervous system neoplasm	3.1e-05	0.000452	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000452	CcSEcCtD
Carmustine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	3.1e-05	0.000451	CcSEcCtD
Carmustine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	3.08e-05	0.000449	CcSEcCtD
Carmustine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	3.08e-05	0.000449	CcSEcCtD
Carmustine—Nausea—Topotecan—peripheral nervous system neoplasm	3.08e-05	0.000449	CcSEcCtD
Carmustine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	3.07e-05	0.000447	CcSEcCtD
Carmustine—Confusional state—Etoposide—peripheral nervous system neoplasm	3.07e-05	0.000447	CcSEcCtD
Carmustine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000446	CcSEcCtD
Carmustine—Nausea—Tretinoin—peripheral nervous system neoplasm	3.05e-05	0.000445	CcSEcCtD
Carmustine—Nausea—Isotretinoin—peripheral nervous system neoplasm	3.05e-05	0.000445	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	3.02e-05	0.000441	CcSEcCtD
Carmustine—Infection—Etoposide—peripheral nervous system neoplasm	3.02e-05	0.00044	CcSEcCtD
Carmustine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.00044	CcSEcCtD
Carmustine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	3.02e-05	0.000439	CcSEcCtD
Carmustine—Nausea—Melphalan—peripheral nervous system neoplasm	3.01e-05	0.000439	CcSEcCtD
Carmustine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000437	CcSEcCtD
Carmustine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	2.98e-05	0.000434	CcSEcCtD
Carmustine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	2.98e-05	0.000434	CcSEcCtD
Carmustine—Tachycardia—Etoposide—peripheral nervous system neoplasm	2.97e-05	0.000433	CcSEcCtD
Carmustine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	2.97e-05	0.000433	CcSEcCtD
Carmustine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	2.97e-05	0.000433	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000432	CcSEcCtD
Carmustine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	2.96e-05	0.000431	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000426	CcSEcCtD
Carmustine—Anorexia—Etoposide—peripheral nervous system neoplasm	2.9e-05	0.000423	CcSEcCtD
Carmustine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	2.89e-05	0.000421	CcSEcCtD
Carmustine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	2.88e-05	0.000419	CcSEcCtD
Carmustine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	2.87e-05	0.000418	CcSEcCtD
Carmustine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	2.87e-05	0.000418	CcSEcCtD
Carmustine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	2.85e-05	0.000415	CcSEcCtD
Carmustine—Hypotension—Etoposide—peripheral nervous system neoplasm	2.84e-05	0.000414	CcSEcCtD
Carmustine—Pain—Cisplatin—peripheral nervous system neoplasm	2.84e-05	0.000414	CcSEcCtD
Carmustine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000413	CcSEcCtD
Carmustine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000409	CcSEcCtD
Carmustine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	2.8e-05	0.000407	CcSEcCtD
Carmustine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000404	CcSEcCtD
Carmustine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	2.77e-05	0.000403	CcSEcCtD
Carmustine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	2.74e-05	0.000399	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—EED—peripheral nervous system neoplasm	2.73e-05	0.0731	CbGpPWpGaD
Carmustine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	2.73e-05	0.000398	CcSEcCtD
Carmustine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	2.71e-05	0.000395	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	2.7e-05	0.000394	CcSEcCtD
Carmustine—Somnolence—Etoposide—peripheral nervous system neoplasm	2.7e-05	0.000394	CcSEcCtD
Carmustine—Asthenia—Vincristine—peripheral nervous system neoplasm	2.69e-05	0.000393	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000392	CcSEcCtD
Carmustine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	2.67e-05	0.000389	CcSEcCtD
Carmustine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	2.67e-05	0.000389	CcSEcCtD
Carmustine—Rash—Dactinomycin—peripheral nervous system neoplasm	2.65e-05	0.000386	CcSEcCtD
Carmustine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	2.64e-05	0.000385	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000384	CcSEcCtD
Carmustine—Renal failure—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000383	CcSEcCtD
Carmustine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	2.63e-05	0.000383	CcSEcCtD
Carmustine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	2.62e-05	0.000382	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000382	CcSEcCtD
Carmustine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	2.61e-05	0.00038	CcSEcCtD
Carmustine—Constipation—Etoposide—peripheral nervous system neoplasm	2.6e-05	0.000379	CcSEcCtD
Carmustine—Pain—Etoposide—peripheral nervous system neoplasm	2.6e-05	0.000379	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000379	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000378	CcSEcCtD
Carmustine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	2.58e-05	0.000376	CcSEcCtD
Carmustine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	2.57e-05	0.000374	CcSEcCtD
Carmustine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	2.51e-05	0.000365	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000365	CcSEcCtD
Carmustine—Nausea—Dactinomycin—peripheral nervous system neoplasm	2.5e-05	0.000364	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000363	CcSEcCtD
Carmustine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	2.49e-05	0.000362	CcSEcCtD
Carmustine—Dizziness—Vincristine—peripheral nervous system neoplasm	2.48e-05	0.000362	CcSEcCtD
Carmustine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	2.48e-05	0.000361	CcSEcCtD
Carmustine—Rash—Alitretinoin—peripheral nervous system neoplasm	2.46e-05	0.000358	CcSEcCtD
Carmustine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	2.45e-05	0.000358	CcSEcCtD
Carmustine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	2.45e-05	0.000356	CcSEcCtD
Carmustine—Headache—Alitretinoin—peripheral nervous system neoplasm	2.44e-05	0.000356	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000354	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000353	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	2.41e-05	0.000351	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000351	CcSEcCtD
Carmustine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	2.4e-05	0.00035	CcSEcCtD
Carmustine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	2.4e-05	0.00035	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.00035	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	2.4e-05	0.00035	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000348	CcSEcCtD
Carmustine—Vomiting—Vincristine—peripheral nervous system neoplasm	2.39e-05	0.000348	CcSEcCtD
Carmustine—Asthenia—Cisplatin—peripheral nervous system neoplasm	2.38e-05	0.000347	CcSEcCtD
Carmustine—Rash—Vincristine—peripheral nervous system neoplasm	2.37e-05	0.000345	CcSEcCtD
Carmustine—Dermatitis—Vincristine—peripheral nervous system neoplasm	2.37e-05	0.000345	CcSEcCtD
Carmustine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000345	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000344	CcSEcCtD
Carmustine—Headache—Vincristine—peripheral nervous system neoplasm	2.35e-05	0.000343	CcSEcCtD
Carmustine—Nausea—Alitretinoin—peripheral nervous system neoplasm	2.31e-05	0.000337	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000337	CcSEcCtD
Carmustine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	2.27e-05	0.000331	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000327	CcSEcCtD
Carmustine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	2.24e-05	0.000327	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	0.000325	CcSEcCtD
Carmustine—Nausea—Vincristine—peripheral nervous system neoplasm	2.23e-05	0.000325	CcSEcCtD
Carmustine—Flushing—Epirubicin—peripheral nervous system neoplasm	2.23e-05	0.000325	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	0.000324	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000322	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000319	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	2.18e-05	0.0584	CbGpPWpGaD
Carmustine—Asthenia—Etoposide—peripheral nervous system neoplasm	2.18e-05	0.000318	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	0.000318	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	2.14e-05	0.000312	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000312	CcSEcCtD
Carmustine—Alopecia—Epirubicin—peripheral nervous system neoplasm	2.12e-05	0.000309	CcSEcCtD
Carmustine—Vomiting—Cisplatin—peripheral nervous system neoplasm	2.11e-05	0.000308	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	2.1e-05	0.000306	CcSEcCtD
Carmustine—Rash—Cisplatin—peripheral nervous system neoplasm	2.09e-05	0.000305	CcSEcCtD
Carmustine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	2.09e-05	0.000305	CcSEcCtD
Carmustine—Erythema—Epirubicin—peripheral nervous system neoplasm	2.09e-05	0.000304	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	2.09e-05	0.000304	CcSEcCtD
Carmustine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	2.08e-05	0.000303	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.000302	CcSEcCtD
Carmustine—Flushing—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	0.0003	CcSEcCtD
Carmustine—Back pain—Epirubicin—peripheral nervous system neoplasm	2.02e-05	0.000294	CcSEcCtD
Carmustine—Dizziness—Etoposide—peripheral nervous system neoplasm	2.01e-05	0.000293	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.98e-05	0.000289	CcSEcCtD
Carmustine—Nausea—Cisplatin—peripheral nervous system neoplasm	1.97e-05	0.000287	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.000287	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.96e-05	0.000286	CcSEcCtD
Carmustine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	0.000283	CcSEcCtD
Carmustine—Vomiting—Etoposide—peripheral nervous system neoplasm	1.93e-05	0.000282	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	1.93e-05	0.000282	CcSEcCtD
Carmustine—Erythema—Doxorubicin—peripheral nervous system neoplasm	1.93e-05	0.000282	CcSEcCtD
Carmustine—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.93e-05	0.000281	CcSEcCtD
Carmustine—Agitation—Epirubicin—peripheral nervous system neoplasm	1.92e-05	0.00028	CcSEcCtD
Carmustine—Rash—Etoposide—peripheral nervous system neoplasm	1.92e-05	0.000279	CcSEcCtD
Carmustine—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.92e-05	0.000279	CcSEcCtD
Carmustine—Headache—Etoposide—peripheral nervous system neoplasm	1.91e-05	0.000278	CcSEcCtD
Carmustine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000273	CcSEcCtD
Carmustine—Back pain—Doxorubicin—peripheral nervous system neoplasm	1.87e-05	0.000272	CcSEcCtD
Carmustine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	0.000265	CcSEcCtD
Carmustine—Convulsion—Epirubicin—peripheral nervous system neoplasm	1.81e-05	0.000264	CcSEcCtD
Carmustine—Nausea—Etoposide—peripheral nervous system neoplasm	1.81e-05	0.000263	CcSEcCtD
Carmustine—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.8e-05	0.000263	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.79e-05	0.00026	CcSEcCtD
Carmustine—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000259	CcSEcCtD
Carmustine—Myalgia—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000259	CcSEcCtD
Carmustine—Agitation—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	0.000259	CcSEcCtD
Carmustine—Anxiety—Epirubicin—peripheral nervous system neoplasm	1.77e-05	0.000258	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000252	CcSEcCtD
Carmustine—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.72e-05	0.000251	CcSEcCtD
Carmustine—Oedema—Epirubicin—peripheral nervous system neoplasm	1.7e-05	0.000248	CcSEcCtD
Carmustine—Infection—Epirubicin—peripheral nervous system neoplasm	1.69e-05	0.000247	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000244	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.67e-05	0.000243	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000243	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	1.66e-05	0.000242	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.00024	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.00024	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000239	CcSEcCtD
Carmustine—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.63e-05	0.000237	CcSEcCtD
Carmustine—Hypotension—Epirubicin—peripheral nervous system neoplasm	1.59e-05	0.000232	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.59e-05	0.000232	CcSEcCtD
Carmustine—Oedema—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.00023	CcSEcCtD
Carmustine—Infection—Doxorubicin—peripheral nervous system neoplasm	1.57e-05	0.000228	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	1.55e-05	0.000226	CcSEcCtD
Carmustine—GSR—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.55e-05	0.0414	CbGpPWpGaD
Carmustine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	0.000225	CcSEcCtD
Carmustine—Insomnia—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000225	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	0.000224	CcSEcCtD
Carmustine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.53e-05	0.000223	CcSEcCtD
Carmustine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.52e-05	0.000222	CcSEcCtD
Carmustine—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.52e-05	0.000221	CcSEcCtD
Carmustine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.5e-05	0.000219	CcSEcCtD
Carmustine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.48e-05	0.000216	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.47e-05	0.000215	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000215	CcSEcCtD
Carmustine—Pain—Epirubicin—peripheral nervous system neoplasm	1.46e-05	0.000212	CcSEcCtD
Carmustine—Constipation—Epirubicin—peripheral nervous system neoplasm	1.46e-05	0.000212	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	1.44e-05	0.000209	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	1.43e-05	0.000208	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.42e-05	0.000206	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.000205	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.4e-05	0.000205	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	1.4e-05	0.000204	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.39e-05	0.000203	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.37e-05	0.0002	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000198	CcSEcCtD
Carmustine—Constipation—Doxorubicin—peripheral nervous system neoplasm	1.35e-05	0.000197	CcSEcCtD
Carmustine—Pain—Doxorubicin—peripheral nervous system neoplasm	1.35e-05	0.000197	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000196	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000196	CcSEcCtD
Carmustine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.3e-05	0.000189	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.000188	CcSEcCtD
Carmustine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000183	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000182	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000182	CcSEcCtD
Carmustine—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.22e-05	0.000178	CcSEcCtD
Carmustine—GSR—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.19e-05	0.0318	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.00017	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000169	CcSEcCtD
Carmustine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.13e-05	0.000165	CcSEcCtD
Carmustine—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.13e-05	0.000164	CcSEcCtD
Carmustine—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.08e-05	0.000158	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000157	CcSEcCtD
Carmustine—Rash—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000157	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000157	CcSEcCtD
Carmustine—Headache—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000156	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.04e-05	0.000152	CcSEcCtD
Carmustine—Nausea—Epirubicin—peripheral nervous system neoplasm	1.01e-05	0.000148	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1e-05	0.000146	CcSEcCtD
Carmustine—Rash—Doxorubicin—peripheral nervous system neoplasm	9.95e-06	0.000145	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.94e-06	0.000145	CcSEcCtD
Carmustine—Headache—Doxorubicin—peripheral nervous system neoplasm	9.88e-06	0.000144	CcSEcCtD
Carmustine—GSR—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.75e-06	0.0261	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	9.58e-06	0.0256	CbGpPWpGaD
Carmustine—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.37e-06	0.000137	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	7.15e-06	0.0191	CbGpPWpGaD
Carmustine—GSR—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.58e-06	0.0176	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.83e-06	0.0129	CbGpPWpGaD
Carmustine—GSR—Metabolism—GNS—peripheral nervous system neoplasm	4.76e-06	0.0127	CbGpPWpGaD
Carmustine—GSR—Metabolism—NME1—peripheral nervous system neoplasm	4.56e-06	0.0122	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	4.46e-06	0.0119	CbGpPWpGaD
Carmustine—GSR—Metabolism—COX2—peripheral nervous system neoplasm	4.39e-06	0.0117	CbGpPWpGaD
Carmustine—GSR—Metabolism—ENO2—peripheral nervous system neoplasm	2.88e-06	0.00771	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TP53—peripheral nervous system neoplasm	2.48e-06	0.00663	CbGpPWpGaD
Carmustine—GSR—Metabolism—BCHE—peripheral nervous system neoplasm	2.44e-06	0.00651	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.32e-06	0.00621	CbGpPWpGaD
Carmustine—GSR—Metabolism—TH—peripheral nervous system neoplasm	2.29e-06	0.00612	CbGpPWpGaD
Carmustine—GSR—Metabolism—GNAS—peripheral nervous system neoplasm	1.87e-06	0.005	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCB1—peripheral nervous system neoplasm	1.84e-06	0.00491	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.82e-06	0.00486	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.62e-06	0.00432	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.5e-06	0.00402	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.2e-06	0.00321	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.18e-06	0.00316	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.1e-07	0.00217	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.73e-07	0.0018	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	5.86e-07	0.00157	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	5.62e-07	0.0015	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	5.41e-07	0.00145	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—peripheral nervous system neoplasm	5.05e-07	0.00135	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	3.55e-07	0.000949	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3e-07	0.000802	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.86e-07	0.000765	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	2.82e-07	0.000754	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.3e-07	0.000615	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.26e-07	0.000604	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	6.21e-08	0.000166	CbGpPWpGaD
